Pharma news
Americas
Scott Kamholz, a former judge at the Patent Trial and Appeal Board, recently returned to law firm Foley Hoag as partner. LSIPR spoke to him at this year’s BIO International Convention, where he explained why the inter-partes review is not a “death squad” for patents. 18 June 2015
Americas
The Transatlantic Trade and Investment Partnership has the potential to reinforce intellectual property as a driver of innovation, said Washington, DC-based former lawyer Jennifer Hillman at the BIO International Convention on Tuesday. 17 June 2015
Americas
Jacqueline Wright Bonilla, an administrative judge at the US Patent and Trademark Office, has told the BIO International Convention that despite inter partes review proceedings appearing to favour petitioners, the USPTO is not pro-petitioner, patent owner or even IPR. 17 June 2015
Americas
US law firm Blank Rome has hired Paul Zagar as a partner to its intellectual property group. 17 June 2015
Asia
Two writ petitions to the Delhi High Court have resulted in the formation of a committee tasked with devising approaches to promote expedited examination at the Indian Patent Office, as Pravin Anand of Anand and Anand reports. 16 June 2015
Americas
The inter partes review system was set up as a cheaper way of invalidating patents than litigation. Given the high success rate, and the large number of ‘patent trolls’ involved, is it likely that troll activity will be dampened? Steve Coyle, Leslie-Anne Maxwell and Chad Dever of Cantor Colburn investigate. 16 June 2015
Americas
Recent changes in US patent law have made protecting and enforcing patents directed to digital healthcare inventions more challenging, as Marsha Gillentine and Michelle Holoubek of Sterne, Kessler, Goldstein & Fox explain. 16 June 2015
Americas
The pharmaceutical and biotechnology industries are in “very good shape” and the so-called patent cliff is “firmly in the rear view mirror”, according to a report by life sciences market research company Evaluate. 16 June 2015
Pharma
This year’s Life Sciences Law Forum is taking place on June 25 in London. LSIPR caught up with the conference’s chair James Horgan, of Merck Sharp & Dohme, and GlaxoSmithKline counsel Anthony Kenny to find out what’s keeping them busy and what they’ll discuss on the day. 16 June 2015
Pharma
How will the OECD’s Modified Nexus Approach to innovator-friendly tax regimes such as the UK’s patent box affect the life sciences industry? LSIPR investigates. 16 June 2015